A microbiota-driven neuroepithelial feed-forward circuit drives gastroesophageal junction tumorigenesis
- 1Columbia University Irving Medical Center
Abstract
The gastroesophageal junction (GEJ) is continuously exposed to refluxed bile acids and microbial perturbations, yet how these environmental cues are converted into persistent oncogenic signaling is unknown. Here we show that bile acid remodeling enriches the oral commensal Prevotella melaninogenica at the GEJ, where bacterial succinate activates both vagal sensory neurons and SUCNR1-expressing tuft cells. Activated tuft cells release 15-deoxy-12,14-prostaglandin J2 (15-d-PGJ2), which sensitizes sensory neurons and sustains nerve remodeling, while neuronal CGRP drives expansion and tuft-cell differentiation of neuro-responsive epithelial progenitors through RAMP1. This self-reinforcing microbiota-neuron-epithelium circuit promotes dysplastic progression, and its genetic or pharmacological disruption, including with the approved CGRP antagonist rimegepant, suppresses tumor development, revealing an interceptable mechanism linking environmental dysbiosis to cancer initiation through neural circuits.
Related
- A solitary brain metastasis from gastroesophageal junction adenocarcinoma 13 years after curative multimodality treatment: a case report and review of the literature
- Progression-free survival of 23 months with second-line trastuzumab deruxtecan in HER2-positive gastroesophageal junction adenocarcinoma: a case report
- Neoadjuvant immunotherapy for locally advanced resectable gastric and gastroesophageal junction adenocarcinoma: a systematic review and meta-analysis.
- Association of endoscopic and CT response with pathological response after preoperative FLOT-based therapy for gastric and gastroesophageal junction cancer: a retrospective cohort study
- Prognostic associations between patient-reported outcomes and progression-free and overall survival in advanced gastric or gastroesophageal junction adenocarcinoma with PD-L1 TAP score ≥ 5%: results from the RATIONALE-305 trial
BibTeX
@misc{zeng2026microbiotadriven,
title = {{A microbiota-driven neuroepithelial feed-forward circuit drives gastroesophageal junction tumorigenesis}},
author = {Y. Zeng and Z. Ye and F. Wu and P. Zhang and H. KOBAYASHI and J. Arai and X. Zhi and M. Borgmann and J. Qian and S. Li and B. Zheng and H. Zheng and R. Tu and J. Lin and M. Hata and Y. Ochiai and Q. Waterbury and N. Harry and L. Zamechek and K. Vasilew and M. Quante and J. Abrams and J. G. Fox and T. C. WANG},
howpublished = {bioRxiv},
year = {2026},
month = oct,
doi = {10.64898/2026.10.13.759004},
url = {https://www.biorxiv.org/content/10.64898/2026.10.13.759004v1},
note = {CC BY-NC-ND},
}
RIS
TY - UNPB
TI - A microbiota-driven neuroepithelial feed-forward circuit drives gastroesophageal junction tumorigenesis
AU - Y. Zeng
AU - Z. Ye
AU - F. Wu
AU - P. Zhang
AU - H. KOBAYASHI
AU - J. Arai
AU - X. Zhi
AU - M. Borgmann
AU - J. Qian
AU - S. Li
AU - B. Zheng
AU - H. Zheng
AU - R. Tu
AU - J. Lin
AU - M. Hata
AU - Y. Ochiai
AU - Q. Waterbury
AU - N. Harry
AU - L. Zamechek
AU - K. Vasilew
AU - M. Quante
AU - J. Abrams
AU - J. G. Fox
AU - T. C. WANG
PY - 2026
DA - 2026/10/13
PB - bioRxiv
DO - 10.64898/2026.10.13.759004
UR - https://www.biorxiv.org/content/10.64898/2026.10.13.759004v1
AB - The gastroesophageal junction (GEJ) is continuously exposed to refluxed bile acids and microbial perturbations, yet how these environmental cues are converted into persistent oncogenic signaling is unknown. Here we show that bile acid remodeling enriches the oral commensal Prevotella melaninogenica at the GEJ, where bacterial succinate activates both vagal sensory neurons and SUCNR1-expressing tuft cells. Activated tuft cells release 15-deoxy-12,14-prostaglandin J2 (15-d-PGJ2), which sensitizes sensory neurons and sustains nerve remodeling, while neuronal CGRP drives expansion and tuft-cell differentiation of neuro-responsive epithelial progenitors through RAMP1. This self-reinforcing microbiota-neuron-epithelium circuit promotes dysplastic progression, and its genetic or pharmacological disruption, including with the approved CGRP antagonist rimegepant, suppresses tumor development, revealing an interceptable mechanism linking environmental dysbiosis to cancer initiation through neural circuits.
ER -